The Republic of Iceland – Government Debt Management
| Series | RIKB 22 1026 | ||
| Settlement Date | 03/10/2021 | ||
| Total Amount Allocated (MM) | 5,400 | ||
| All Bids Awarded At (Price / Yield) | 109.250 | / | 1.460 |
| Total Number of Bids Received | 2 | ||
| Total Amount of All Bids Received (MM) | 5,400 | ||
| Total Number of Successful Bids | 2 | ||
| Number of Bids Allocated in Full | 2 | ||
| Lowest Price / Highest Yield Allocated | 109.250 | / | 1.460 |
| Highest Price / Lowest Yield Allocated | 109.250 | / | 1.460 |
| Lowest Price / Highest Yield Allocated in Full | 109.250 | / | 1.460 |
| Weighted Average of Successful Bids (Price/Yield) | 109.250 | / | 1.460 |
| Best Bid (Price / Yield) | 109.250 | / | 1.460 |
| Worst Bid (Price / Yield) | 109.250 | / | 1.460 |
| Weighted Average of All Bids Received (Price / Yield) | 109.250 | / | 1.460 |
| Percentage Partial Allocation (Approximate) | 100.00 % | ||
| Bid to Cover Ratio | 1.00 | ||
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
King Faisal Prize7.1.2026 19:01:34 CET | Press release
Pioneering Scientist Behind Revolutionary Weight-Loss Drugs and Leading Mathematician Honored with 2026 King Faisal Prize
Herantis Pharma plc7.1.2026 19:01:06 CET | Press release
Herantis Pharma - Phase 1b biomarker data show clear evidence of biological response to HER-096 in people with Parkinson's disease
Theon International PLC7.1.2026 18:43:56 CET | Press release
THEON completes the acquisition of a circa 9.8% stake in Exosens
Modelo7.1.2026 18:41:51 CET | Press release
UPDATE - Big Flavor, Zero Compromise: Modelo® Debuts First-Ever Non-Alcoholic Option
VALLOUREC7.1.2026 18:00:00 CET | Press release
VALLOUREC INITIATES A €200 MILLION SHARE BUYBACK AND TARGETS TOTAL SHAREHOLDER RETURN TO BE AT LEAST €500 MILLION BY AUGUST 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom